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Alcohol has been hypothesized to promote ovarian carcinogenesis by its potential to increase circulating levels of estrogen and other
hormones; through its oxidation byproduct, acetaldehyde, which may act as a cocarcinogen; and by depletion of folate and other
nutrients. Case–control and cohort studies have reported conflicting results relating alcohol intake to ovarian cancer risk. We
conducted a pooled analysis of the primary data from ten prospective cohort studies. The analysis included 529638 women among
whom 2001 incident epithelial ovarian cases were documented. After study-specific relative risks (RR) and 95% confidence intervals
(CI) were calculated by Cox proportional hazards models, and then were pooled using a random effects model; no associations were
observed for intakes of total alcohol (pooled multivariate RR¼1.12, 95% CI 0.86–1.44 comparing X30 to 0gday
 1 of alcohol) or
alcohol from wine, beer or spirits and ovarian cancer risk. The association with alcohol consumption was not modified by oral
contraceptive use, hormone replacement therapy, parity, menopausal status, folate intake, body mass index, or smoking. Associations
for endometrioid, mucinous, and serous ovarian cancer were similar to the overall findings. This pooled analysis does not support an
association between moderate alcohol intake and ovarian cancer risk.
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Alcohol intake has been associated with a higher risk of cancers of
the upper alimentary tract, liver, large intestine, and breast (Poschl
and Seitz, 2004). Alcohol has been theorized to promote
carcinogenesis by its potential to increase circulating levels of
oestrogen and other hormones; through its oxidation byproduct,
acetaldehyde, which may act as a cocarcinogen; by induction of
cytochrome P450 enzymes which are involved in the activation of
liver carcinogens; and by depletion of folate (Poschl and Seitz,
2004). In contrast, alcohol has also been hypothesized to prevent
ovarian carcinogenesis by decreasing follicle stimulating hormone
(Gavaler and van Thiel, 1992), luteinizing hormone (Gavaler and
van Thiel, 1992) and gonadotropins (Verkasalo et al, 2001) levels,
all of which have been hypothesized to increase ovarian cancer risk
(Cramer and Welch, 1983).
Several epidemiologic studies have examined the association
between alcohol consumption and ovarian cancer risk (McCann
et al, 2003; Modugno et al, 2003; Kelemen et al, 2004; Larsson et al,
2004; Riman et al, 2004; Webb et al, 2004). A recent meta-analysis
reported a 30% lower risk of ovarian cancer risk with higher
intakes of alcohol (Webb et al, 2004) for population based case–
control and cohort studies, but found no association for hospital-
based case–control studies. Overall, the results from cohort
studies of women with alcoholism have been nonstatistically
significant, with suggestions of positive and inverse associations
between alcohol intake and ovarian cancer risk (Webb et al, 2004).
One of two case–control studies has found that alcohol intake was
positively associated with risk of mucinous tumours (Kuper et al,
2000; Modugno et al, 2003).
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p
i
d
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i
o
l
o
g
yOwing to the potential for recall bias in case–control studies
and the small number of cases in most cohort studies, we
investigated the associations between alcohol intake and ovarian
cancer risk in a pooled analysis of several prospective studies.
As the effect of alcohol may vary by potential ovarian cancer risk
factors, we also considered whether the association differed
by hormonal, environmental and nutritional factors. We also
examined associations separately for endometrioid, mucinous, and
serous ovarian cancers.
MATERIALS AND METHODS
Population
A pooled analysis of the primary data from 10 prospective cohort
studies (Bandera et al, 1997; Rockhill et al, 1998; Bertone et al,
2002; Calle et al, 2002; Lacey et al, 2002; Terry et al, 2003; Kelemen
et al, 2004; Larsson et al, 2004; Lin et al, 2004; Schouten et al, 2004)
was conducted in The Pooling Project of Prospective Studies of
Diet and Cancer (Table 1). To be included in this analysis, each
study needed a minimum of 50 incident ovarian cancer cases, an
assessment of usual diet, including alcohol intake, and validation
of the dietary assessment tool or a closely related instrument.
Two studies, the Canadian National Breast Screening Study and
Netherlands Cohort Study, were analysed as case-cohort studies
because the investigators have processed questionnaires for newly
diagnosed cases and a random sample of noncases to represent the
person-time of the entire study population. The follow-up of the
Nurses’ Health Study was divided into two sections where NHS (a)
followed individuals from the completion of the 1980 food
frequency questionnaire (FFQ) to 1986, and NHS (b) followed
those individuals still at risk from the completion of the 1986 FFQ
(a more comprehensive FFQ compared to the 1980 questionnaire)
to 2002. The methods for the Pooling Project have been described
in detail elsewhere (Smith-Warner et al, in press).
Exclusions
In addition to applying the exclusions that each study had
predefined for their cohort, we excluded individuals if they had
a prior cancer diagnosis other than nonmelanoma skin cancer at
baseline, had a bilateral oophorectomy prior to baseline, had loge-
transformed energy intakes beyond 3 s.d. from the study-specific
loge-transformed mean energy intake of their respective popula-
tion, or had missing alcohol intake data. The New York State
Cohort (Bandera et al, 1997) did not obtain information on
oophorectomy at baseline, and thus we were not able to apply that
exclusion there.
Exposure assessment
Usual dietary intake was estimated at baseline from study-specific
FFQs. All studies, except the New York State Cohort, measured
alcohol intake from wine, beer, and spirits (see Table 1). In these
studies, daily alcohol intake in grams was calculated for each
beverage based on the reported frequency of consumption,
the alcohol content of the beverage, and the average quantity
consumed. The alcohol intake from each specific beverage was
summed to estimate total alcohol intake. Intakes of other nutrients
were estimated using a similar approach. In the New York State
Cohort, the ‘regression weight’ method was used to estimate
nutrient and alcohol values (Bandera et al, 1997). Correlations
between energy-adjusted alcohol intake measured from the study-
specific FFQ or a closely related instrument and multiple 24h
recalls or food records generally exceeded 0.77 for total alcohol
intake (Giovannucci et al, 1991; Munger et al, 1992; Goldbohm
et al, 1994; Flagg et al, 2000; Wolk et al, personal communication).
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E
p
i
d
e
m
i
o
l
o
g
yInformation on nondietary factors was collected on the baseline
self-administered questionnaires within each study. Most studies
obtained information on multiple reproductive factors, body mass
index, smoking status, and physical activity.
Outcome assessment
Participants were followed from the date of the baseline
questionnaire until date of ovarian cancer diagnosis, date of
death, date the participant moved out of the study area (if
applicable), or end of follow-up, whichever came first. Invasive
epithelial ovarian cancer, defined by ICD-9 code 183.0 or ICD-10
code C56, was ascertained by self-report with subsequent medical
record review, cancer registry linkage, or both. Some studies
additionally obtained information from death registries (Smith-
Warner et al, in press). Borderline and nonepithelial ovarian
cancer cases, as determined by International Classification of
Diseases for Oncology morphology codes (Percy et al, 1990) or the
histological information supplied by individual studies, were not
included as cases.
Statistical analysis
Alcohol intake was modelled categorically within each individual
study using identical absolute cutpoints. Studies were excluded
from the analysis if they did not measure intake of that specific
beverage or if that beverage was not consumed in that population.
Relative risks (RR) and 95% confidence intervals (CI) were
calculated by Cox proportional hazards models (Cox, 1972) for
each study. The models included stratification by age (years) at
baseline and the calendar year at start of follow-up, and treated
follow-up time (years) as the time scale. Multivariate relative risks
were adjusted for age at menarche, menopausal status at baseline,
oral contraceptive use, hormone replacement therapy use among
postmenopausal women, parity, body mass index, smoking status,
physical activity, and energy intake, modelled identically across
studies. An indicator variable for missing values was also
generated within a study for each covariate, if applicable (Smith-
Warner et al, in press). To test whether there was a linear trend in
the risk of disease with increasing alcohol intake, a continuous
variable with values corresponding to the median value for each
exposure category was included in the model; the coefficient for
that variable was evaluated using the Wald test. SAS software
(Allison, 1995) was used for the cohort analyses, and Epicure
software (1993) was used for the case-cohort analyses.
Study-specific relative risks were pooled using a random effects
model (DerSimonian and Laird, 1986). The study-specific relative
risks were weighted by the inverse of the sum of their variance and
the estimated between-studies variance component. Between-
studies heterogeneity was evaluated using the Q statistic (Cochran,
1954; DerSimonian and Laird, 1986).
We also tested whether the associations for alcohol from beer,
wine, and liquor and ovarian cancer risk differed by using a
contrast test for the pooled estimates for each beverage and their
covariance matrix from the random-effects model. The test
statistic followed approximately a w
2 distribution with 2 degrees
of freedom (Anderson, 1984). For each study, we corrected the
relative risk for total alcohol intake for measurement error using
the regression coefficients between alcohol intakes estimated by
the FFQs and reference methods (Rosner et al, 1989, 1990).
We also evaluated whether alcohol intake was linearly associated
with ovarian cancer risk by comparing nonparametric regression
curves using restricted cubic splines to the linear model using the
likelihood ratio test, and by visual inspection of the restricted
cubic spline graphs (Smith, 1979; Durrleman and Simon, 1989).
The studies were combined into a single data set, and analysed as
above, additionally stratified by study. Owing to the small numbers
of individuals consuming high amounts of alcohol, this analysis
was limited to women consuming o60gday
 1 of alcohol.
Further analyses were conducted to examine whether the
association between alcohol consumption and ovarian cancer risk
varied by hormonal, environmental and nutritional factors. As
most studies collected information at baseline only, for analyses
evaluating whether menopausal status modified the association
between alcohol consumption and ovarian cancer risk, we assigned
menopausal status at follow-up in each study using a previously
described algorithm (Smith-Warner et al, 1998). For each factor,
an interaction term between the level of each factor and alcohol
intake expressed as a continuous variable was included in the
model. Participants with missing values of the modifying factor
were excluded from these analyses. Separate analyses were also
conducted for endometrioid, mucinous, and serous subtypes
among those studies having more than 10 cases of the specific
subtype. Subtype analyses were conducted among these three
histologies since they are the three most common, representing
68% of all ovarian cancer cases in our population. We tested
whether results differed across the subtypes using a contrast test
(Anderson, 1984).
RESULTS
The total study population consisted of 529638 women among
whom 2001 developed invasive epithelial ovarian cancer over 4.6
million person years (Table 1). The percentage of alcohol drinkers
in each study ranged from 45 to 78%. Median total alcohol intake
among drinkers was low and ranged from 1.9 to 6.6gday
 1.
Alcohol intake was not associated with ovarian cancer risk
(pooled age-adjusted RR¼1.11, 95% CI: 0.87–1.43 and multi-
variate RR¼1.12, 95% CI: 0.86–1.44) comparing X30 to 0gday
 1
(Table 2). There was no significant between-studies heterogeneity
(P-value, test for between-studies heterogeneity 40.50). Likewise,
no association was observed for alcohol from individual beverages
and ovarian cancer risk (Table 3). Results were similar after
excluding nondrinkers (data not shown).
The nonparametric regression curve also showed no association
with alcohol intake and ovarian cancer risk (test for linearity,
P40.05) (data not shown). Among the five studies that assessed
alcohol intake in validation studies (Giovannucci et al, 1991;
Munger et al, 1992; Goldbohm et al, 1994; Flagg et al, 2000; Wolk
et al, personal communication), the pooled age and energy-
adjusted relative risk for an increment of 15gday
 1 of alcohol
(equivalent to approximately one serving of alcohol) changed from
1.01 (95% CI: 0.91–1.11) to 1.04 (95% CI: 0.92–1.18; P-value, test
for between studies heterogeneity¼0.91) after correction for
measurement error in the assessment of alcohol consumption.
For all cohorts, the pooled multivariate RR for this increment was
1.01 (95% CI: 0.93–1.11). In analyses that simultaneously adjusted
for intakes of alcohol from wine, beer, and spirits as continuous
variables (increment¼15gday
 1), we found no association of
alcohol from wine (pooled multivariate RR¼1.07, 95% CI: 0.95–
1.21), beer (pooled multivariate RR¼1.02, 95% CI: 0.84–1.24) and
spirits (pooled multivariate RR¼1.03, 95% CI: 0.93–1.14) with
ovarian cancer risk (P-value for the test of difference¼0.83).
These results were similar to those not mutually adjusted for
intake of alcohol from other beverages.
Risk estimates for total alcohol intake were similar for
endometrioid (N¼260, pooled multivariate RR¼1.05, 95% CI:
0.87–1.26), mucinous (N¼121, pooled multivariate RR¼1.06,
95% CI: 0.84–1.34) and serous (N¼981, pooled multivariate
RR¼1.07, 95% CI: 0.98–1.17) ovarian cancers (P-value for
difference by histological type¼0.98).
The association between total alcohol intake and ovarian cancer
risk was not modified by hormonal, environmental and nutritional
factors (Table 4). The relative risks for total alcohol did not differ
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diagnosis (data not shown). Sensitivity analyses in which we
limited analyses to the first 6 years of follow-up compared to six or
more years of follow-up showed similar results to the overall result
(data not shown).
DISCUSSION
In this pooled analysis of prospective studies, no statistically
significant associations were observed for alcohol intake overall, or
from specific beverages, with ovarian cancer risk. In contrast to the
inverse results published in a recent meta-analysis (Webb et al,
2004) of five population-based case–control and two cohort
studies, our null results were similar to those reported in
three recently published population-based case–control studies
(McCann et al, 2003; Modugno et al, 2003; Riman et al, 2004) and
in the meta-analysis (Webb et al, 2004) of seven hospital-based
case–control studies. Unlike two case–control studies (Goodman
and Tung, 2003; Webb et al, 2004), we did not observe an inverse
association between wine intake and ovarian cancer risk.
Two case–control studies have examined alcohol intake in
relation to serous, mucinous, and endometrioid ovarian cancers
risk separately (Kuper et al, 2000; Modugno et al, 2003). One study
saw a higher risk of mucinous ovarian cancer with higher alcohol
intake (Modugno et al, 2003). In contrast, we found no difference
Table 2 Study-specific and pooled multivariate
a adjusted relative risks and 95% confidence intervals for ovarian cancer according to intake of total alcohol
Categories of alcohol intake (gday
 1)
Study 0 1–4.9 5–14.9 15–29.9 X30 PHeterogeneity
c Ptrend
d
Breast Cancer Detection Demonstration
Project Follow-up Study
1.00 (Ref) 1.25 (0.84–1.87) 1.39 (0.82–2.35) 1.70 (0.87–3.33) 2.21 (0.92–5.31) 0.04
Canadian National Breast Screening Study 1.00 (Ref) 0.90 (0.61–1.33) 1.21 (0.81–1.80) 1.10 (0.67–1.81) 1.27 (0.71–2.25) 0.24
Cancer Prevention Study II Nutrition Cohort 1.00 (Ref) 1.07 (0.81–1.41) 0.85 (0.59–1.22) 0.82 (0.43–1.53) 0.79 (0.39–1.58) 0.25
Iowa Women’s Health Study 1.00 (Ref) 1.28 (0.94–1.75) 0.87 (0.53–1.41) 0.71 (0.31–1.64) 0.75 (0.30–1.88) 0.24
Netherlands Cohort Study 1.00 (Ref) 1.06 (0.73–1.52) 1.07 (0.67–1.70) 0.77 (0.39–1.53) 1.79 (0.83–3.85) 0.50
New York State Cohort 1.00 (Ref) 0.98 (0.58–1.65) 0.28 (0.08–0.96) 0.41 (0.09–1.81) 0.53 (0.07–4.02) 0.05
Nurses’ Health Study(a) 1.00 (Ref) 0.90 (0.58–1.40) 0.82 (0.49–1.36) 0.92 (0.44–1.91) 0.78 (0.32–1.87) 0.57
Nurses’ Health Study(b) 1.00 (Ref) 1.13 (0.86–1.50) 0.85 (0.60–1.20) 1.52 (1.01–2.29) 0.87 (0.49–1.56) 0.96
Nurses’ Health Study II 1.00 (Ref) 0.94 (0.52–1.72) 0.73 (0.29–1.83) 0.60 (0.08–4.50) 1.59 (0.21–12.1) 0.84
Swedish Mammography Cohort
b 1.00 (Ref) 1.04 (0.80–1.35) 1.04 (0.68–1.59) 1.19 (0.29–4.85) — 0.79
Women’s Health Study 1.00 (Ref) 0.78 (0.48–1.27) 1.10 (0.65–1.87) 1.04 (0.43–2.49) 1.66 (0.64–4.32) 0.21
Cases 754 729 320 122 76
Pooled 1.00 (Ref) 1.06 (0.95–1.18) 0.96 (0.84–1.11) 1.09 (0.89–1.35) 1.12 (0.86–1.44) 0.50 0.72
aMultivariate relative risks were adjusted for calendar year age at menarche (o13, 13, 413 years), menopausal status at baseline (premenopausal, postmenopausal, dubious),
oral contraceptive use (ever, never), hormone replacement therapy use among postmenopausal women (never, past, current), parity (0, 1, 2, 42,), body mass index (o23, 23-
o25, 25-o30, X30kgm
 2), smoking status (never, past, current), physical activity (low, medium, high), and energy intake (continuous).
bSwedish Mammography Cohort was
not included in the category X30g of alcohol since this study had no cases in that category. The participants who were not cases who would have been in this highest category
were included in the next highest category (15–29.9gday
 1).
cP-value, test for between-studies heterogeneity is for the X30gday
 1 category.
dP-value, test for trend.
Table 3 Pooled age and multivariate
a,b adjusted relative risks (RR) and 95% confidence intervals (CI) for ovarian cancer according to intake of alcohol
from specific beverages
Categories of alcohol intake (gday
 1)
Range 0 1–4.9 5–14.9 X15 PHeterogeneity
f Ptrend
g
Wine
c
Cases 965 719 174 66
Age RR (95% CI) 1.00 (Ref) 1.04 (0.94–1.15) 1.05 (0.89–1.25) 1.21 (0.92–1.60) 0.77 0.35
MV RR (95% CI) 1.00 (Ref) 1.03 (0.93–1.14) 1.03 (0.86–1.23) 1.18 (0.89–1.57) 0.80 0.49
Beer
d
Cases 1462 396 48 18
Age RR (95% CI) 1.00 (Ref) 1.11 (0.98–1.25) 0.76 (0.57–1.02) 1.40 (0.87–2.25) 0.82 0.76
MV RR (95% CI) 1.00 (Ref) 1.09 (0.97–1.24) 0.75 (0.56–1.01) 1.38 (0.85–2.25) 0.87 0.78
Spirits
e
Cases 1335 380 139 70
Age RR (95% CI) 1.00 (Ref) 1.01 (0.89–1.15) 1.03 (0.78–1.37) 1.17 (0.85–1.61) 0.15 0.59
MV RR (95% CI) 1.00 (Ref) 1.01 (0.89–1.15) 1.02 (0.75–1.38) 1.16 (0.85–1.57) 0.21 0.68
aAge adjusted relative risks were adjusted for age and calendar year. Multivariate relative risks were adjusted for the same covariates as the multivariate model in Table 2. In these
analyses, alcohol from wine, beer and spirits were not mutually adjusted.
bNew York State Cohort was not included in these analyses because they did not measure consumption
of alcohol from specific beverages.
cNurses’ Health Study II was not included in the 5–14.9 and X15gday
 1 categories of alcohol from wine since this study had no cases in that
category.
dNurses’ Health Study II and Swedish Mammography Cohort were not included in the X15gday
 1 category of alcohol from beer since these studies had no cases in
that category. The participants who were not cases who would have been in this highest category were included in the next highest category (5–14.9gday
 1).
eSwedish
Mammography Cohort was not included in the X15gday
 1 category of alcohol from spirits since this study had no cases in that category.
fP-value, test for between-studies
heterogeneity is for X15gday
 1 category.
gP-value, test for trend.
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of specific histological types of ovarian cancer. Although some
misclassification is likely to have occurred in our analyses with
regard to classifying cases according to histology, the distribution
of cases according to the three main histological types in our study
was similar to the percent distribution observed in cancer
registries and other studies for the main histological subtypes of
ovarian cancer (Scully, 1977; Chen et al, 2003).
As our analyses were conducted using only a baseline FFQ
covering recent intake, we were unable to assess changes in intakes
of alcohol and other nutrients over time, nor were we able to
evaluate lifetime drinking patterns. Only a few studies have
addressed these additional ways to examine alcohol drinking
habits in relation to ovarian cancer risks and the results have been
heterogenous (Tzonou et al, 1984; Goodman and Tung, 2003).
Additionally, because we measured adult alcohol intake, we may not
have captured the relevant exposure time for ovarian carcinogenesis.
In the studies comprising this pooled analysis, diet was measured
prior to diagnosis of ovarian cancer; thus, a cancer diagnosis would
not have influenced the reporting of alcohol intake. The strength of
our study was our ability to correct for measurement error in
alcohol intake. The measurement error corrected risk estimates
were similar to the uncorrected results which was expected because
the assessments of alcohol intake from the study-specific ques-
tionnaires and multiple 24h recalls or food records have been
shown to be highly correlated (Giovannucci et al, 1991; Munger
et al, 1992; Goldbohm et al, 1994; Flagg et al, 2000; Wolk et al,
personal communication). In addition, we have previously observed
a modest positive association between alcohol intake and breast
(Smith-Warner et al, 1998) and colorectal cancer (Cho et al, 2004)
risk within the Pooling Project suggesting that misclassification of
alcohol intake is not likely to obscure a modest association,
although we cannot rule out the possibility of a small effect.
Although our categorization of covariates was predetermined
according to how each study assessed the covariates on their
questionnaires, one advantage of our study was that we were able
to control for covariates uniformly and classify the main exposures
similarly, thereby lessening a potential source of heterogeneity
across studies. Within our models, we adjusted for most of the
important known ovarian cancer risk factors if they were measured
in a study. In studies that measured all of the covariates that were
included in our multivariate models, results from the age-adjusted
and multivariate models were similar suggesting that confounding
was minimal. Owing to the inclusion of ten cohort studies, we had
far greater statistical power than any individual cohort study to
examine whether associations differed for histological subtypes or
population subgroups.
In summary, we found no association between intakes of alcohol
and alcohol from specific beverages during adulthood and ovarian
cancer risk in this pooled analysis. Similarly, we observed no
association between alcohol consumption and ovarian cancer risk
by histology. Associations with alcohol intake were not modified
by risk or preventive factors for ovarian cancer. Thus, this pooled
analysis does not provide support for an association between
moderate alcohol intake and ovarian cancer risk.
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